| Sartorius AG | 240.00 / +2.30% |
| Date/Time | 02/19 / 17:23 |
| Chg. / Chg.(%) | 5.40 / +2.30% |
| Bid | 237.80 / 4 |
| Ask | 240.00 / 14 |
| Open | 237.80 |
| Previous Close | 234.60 |
| High | 241.60 |
| Low | 235.40 |
| Volume [EUR] | 1,253,070.30 |
| Volume [Units] | 5,226 |
| Price fixings | 271 |
| ISIN | DE0007165631 |
| Security | SRT3/D |
| Exchange | Cboe Europe CXE |
| Type | Stock |
Other Exchanges
| Exchange | Last | Volume | |
|---|---|---|---|
| Xetra | 240.00 |  |
55,120 |
| TradeGate | 241.000 | |
7,018 |
| Turquoise | 240.00 | |
5,594 |
| Cboe Europe .. | 240.00 | |
5,226 |
| Cboe Europe .. | 239.90 | |
2,163 |
| London Inter.. | 240.00 | |
1,396 |
| Stuttgart | 239.600 | |
370 |
| Frankfurt | 240.4000 | |
160 |
| gettex | 240.200 | |
98 |
| Hamburg | 237.80 | |
20 |
| Hannover | 239.80 | |
15 |
| München | 239.80 | |
5 |
| Vienna Globa.. | 240.00 | |
0 |
| Düsseldorf | 236.00 | |
0 |
| Berlin | 235.00 |  |
0 |
| SIX Swiss Ex.. | 179.50 | |
|
| Lang & Schwa.. | 239.400 | |
|
| Nasdaq Other.. | 247.8600 | 100 | |
| EUREX | Options | ||
News
- XBiotech Announces Rapid Enrollment for its Randomized Multi-Center Clinical Study for Bermekimab in Patients with Hidradenitis Suppurativa
11/19/2019 / 14:55 - GlobeNewswire - Worldwide Cell Based Assay & High Content Screening Market Forecasts to 2024 - Candidate Growth, Immuno-oncology, Genomic Blizzard, Technology Convergence, The Insurance Effect
10/29/2019 / 11:55 - GlobeNewswire - XBiotech Announces First Patient Enrolled in Randomized Multi-Center Clinical Study Evaluating Bermekimab Therapy in Patients with Hidradenitis Suppurativa
10/23/2019 / 14:15 - GlobeNewswire - Global $1.78Bn Fermenters Market Outlook, 2025
10/23/2019 / 11:26 - GlobeNewswire - 2019 Report on Cell Harvesting: Market Projected to Grow by $157.2M During 2019-2025
10/22/2019 / 18:05 - GlobeNewswire
Real-time